Somatostatin analogue pasireotide (SOM230) inhibits catecholamine secretion in human pheochromocytoma cells - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancer Letters Année : 2021

Somatostatin analogue pasireotide (SOM230) inhibits catecholamine secretion in human pheochromocytoma cells

Résumé

Increasingly common, neuroendocrine tumors (NETs) are regarded nowadays as neoplasms potentially causing debilitating symptoms and life-threatening medical conditions. Pheochromocytoma is a NET that develops from chromaffin cells of the adrenal medulla, and is responsible for an excessive secretion of catecholamines. Consequently, patients have an increased risk for clinical symptoms such as hypertension, elevated stroke risk and various cardiovascular complications. Somatostatin analogues are among the main anti-secretory medical drugs used in current clinical practice in patient with NETs. However, their impact on pheochromocytoma-associated catecholamine hypersecretion remains incompletely explored. This study investigated the potential efficacy of octreotide and pasireotide (SOM230) on human tumor cells directly cultured from freshly resected pheochromocytomas using an implemented catecholamine secretion measurement by carbon fiber amperometry. SOM230 treatment efficiently inhibited nicotine-induced catecholamine secretion both in bovine chromaffin cells and in human tumor cells whereas octreotide had no effect. Moreover, SOM230 specifically decreased the number of exocytic events by impairing the stimulation-evoked calcium influx as well as the nicotinic receptor-activated inward current in human pheochromocytoma cells. Altogether, our findings indicate that SOM230 acts as an inhibitor of catecholamine secretion through a mechanism involving the nicotinic receptor and might be considered as a potential anti-secretory treatment for patients with pheochromocytoma.
Fichier principal
Vignette du fichier
1-s2.0-S030438352100519X-main.pdf (1.93 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03389020 , version 1 (20-10-2021)

Identifiants

Citer

Laura Streit, Sophie Moog, Sylvain Hugel, Marion Rame, Emeline Tanguy, et al.. Somatostatin analogue pasireotide (SOM230) inhibits catecholamine secretion in human pheochromocytoma cells. Cancer Letters, 2021, 524, pp.232-244. ⟨10.1016/j.canlet.2021.10.009⟩. ⟨hal-03389020⟩
42 Consultations
159 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More